Justin Walsh
Stock Analyst at Jones Trading
(3.40)
# 977
Out of 5,182 analysts
40
Total ratings
45.95%
Success rate
24.87%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANRO Alto Neuroscience | Maintains: Buy | $49 → $44 | $24.94 | +76.42% | 2 | Apr 2, 2026 | |
| NMTC NeuroOne Medical Technologies | Initiates: Buy | $9 | $4.35 | +106.90% | 1 | Mar 2, 2026 | |
| LNTH Lantheus Holdings | Downgrades: Hold | n/a | $85.50 | - | 11 | Feb 27, 2026 | |
| ATAI AtaiBeckley | Initiates: Buy | $16 | $4.14 | +286.47% | 1 | Dec 23, 2025 | |
| PRAX Praxis Precision Medicines | Initiates: Buy | $83 | $324.20 | -74.40% | 1 | Sep 18, 2025 | |
| VNRX VolitionRx | Initiates: Buy | $3 | $2.43 | +23.46% | 1 | Jun 10, 2025 | |
| BLRX BioLineRx | Upgrades: Buy | $12 | $2.86 | +319.11% | 3 | May 30, 2025 | |
| CLNN Clene | Initiates: Buy | $30 | $6.14 | +388.60% | 1 | Apr 23, 2025 | |
| MNPR Monopar Therapeutics | Downgrades: Hold | n/a | $53.25 | - | 1 | Apr 2, 2025 | |
| SER Serina Therapeutics | Initiates: Buy | $11 | $1.82 | +505.39% | 1 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $33.89 | +23.93% | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $3.85 | +471.43% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $4.39 | +264.46% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.38 | +356.62% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $4 | $0.61 | +551.15% | 4 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $3.41 | +486.51% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $360 | $13.85 | +2,499.28% | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,875 | $6.09 | +30,688.18% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $20 | $40.90 | -51.10% | 1 | May 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $440 → $200 | $0.59 | +33,683.78% | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.96 | +410.20% | 1 | Jan 19, 2022 |
Alto Neuroscience
Apr 2, 2026
Maintains: Buy
Price Target: $49 → $44
Current: $24.94
Upside: +76.42%
NeuroOne Medical Technologies
Mar 2, 2026
Initiates: Buy
Price Target: $9
Current: $4.35
Upside: +106.90%
Lantheus Holdings
Feb 27, 2026
Downgrades: Hold
Price Target: n/a
Current: $85.50
Upside: -
AtaiBeckley
Dec 23, 2025
Initiates: Buy
Price Target: $16
Current: $4.14
Upside: +286.47%
Praxis Precision Medicines
Sep 18, 2025
Initiates: Buy
Price Target: $83
Current: $324.20
Upside: -74.40%
VolitionRx
Jun 10, 2025
Initiates: Buy
Price Target: $3
Current: $2.43
Upside: +23.46%
BioLineRx
May 30, 2025
Upgrades: Buy
Price Target: $12
Current: $2.86
Upside: +319.11%
Clene
Apr 23, 2025
Initiates: Buy
Price Target: $30
Current: $6.14
Upside: +388.60%
Monopar Therapeutics
Apr 2, 2025
Downgrades: Hold
Price Target: n/a
Current: $53.25
Upside: -
Serina Therapeutics
Mar 11, 2025
Initiates: Buy
Price Target: $11
Current: $1.82
Upside: +505.39%
Oct 18, 2024
Initiates: Buy
Price Target: $42
Current: $33.89
Upside: +23.93%
May 16, 2024
Maintains: Buy
Price Target: $15 → $22
Current: $3.85
Upside: +471.43%
May 10, 2024
Initiates: Buy
Price Target: $16
Current: $4.39
Upside: +264.46%
Apr 17, 2024
Initiates: Buy
Price Target: $20
Current: $4.38
Upside: +356.62%
Sep 7, 2023
Reinstates: Buy
Price Target: $4
Current: $0.61
Upside: +551.15%
Sep 6, 2023
Initiates: Buy
Price Target: $20
Current: $3.41
Upside: +486.51%
May 16, 2023
Initiates: Buy
Price Target: $360
Current: $13.85
Upside: +2,499.28%
Oct 7, 2022
Initiates: Buy
Price Target: $1,875
Current: $6.09
Upside: +30,688.18%
May 20, 2022
Maintains: Buy
Price Target: $17 → $20
Current: $40.90
Upside: -51.10%
Apr 5, 2022
Maintains: Buy
Price Target: $440 → $200
Current: $0.59
Upside: +33,683.78%
Jan 19, 2022
Initiates: Buy
Price Target: $10
Current: $1.96
Upside: +410.20%